BIOCONVERGENCE LLC v. ATTARIWALA

District Court, S.D. Indiana·Decided December 18, 2019·No. 1:19-cv-01745·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION

) BIOCONVERGENCE LLC ) d/b/a SINGOTA SOLUTIONS, ) ) Plaintiff, ) ) v. ) No. 1:19-cv-01745-SEB-TAB ) JASPREET ATTARIWALA, ) SIMRANJIT JOHNNY SINGH ) a/k/a SIMRANJIT J. ATTARIWALA ) a/k/a SIM J. SINGH, ) ) Defendants. ) ) ) JASPREET ATTARIWALA, ) ) Counter Claimant, ) ) v. ) ) BIOCONVERGENCE LLC, ) ) Counter Defendant. )

ORDER GRANTING PLANTIFF’S MOTION FOR FURTHER PRELIMINARY INJUNCTION [DKT. 84]

This cause is before the Court on Plaintiff’s Motion for Further Preliminary Injunction [Dkt. 84] filed on October 10, 2019. With that motion, Plaintiff BioConvergence LLC d/b/a Singota Solutions (“Singota”) seeks an order supplementing an existing preliminary injunction entered by the Monroe Circuit Court I (Indiana) on March 4, 2019. Singota specifically requests an order enjoining Defendant Jaspreet Attariwala from working for her current employer and Singota’s direct competitor, Emergent BioSolutions, Inc. (“Emergent”), as well as any other competitor based on

alleged violations of the Indiana Uniform Trade Secrets Act. This matter was heard on two occasions by this court, on November 21, 2019, and December 4, 2019. For the reasons detailed in this entry, Plaintiff’s motion is GRANTED. Background

The facts giving rise to this litigation are both prolix and labyrinthine; thankfully, they are largely undisputed by the parties. I. The Parties Singota is a limited liability corporation based in Bloomington, Indiana. [Am. Compl. ¶ 17]. It operates as a contract development and manufacturing organization, sometimes referred to as a “CMO” or “CDMO,” offering services for clients in pharmaceutical, animal health, and medical device industries. [Id. at ¶ 18]. Singota’s

services relate to sterile products that must be administered by injection, and Singota focuses its sterile-product capacity on primarily servicing clients with early-to-mid and late-stage research and development as well as commercial products that require small- scale capacity equipment [Id. at ¶ 19]. In serving its clients, Singota maintains highly confidential information with respect to its clients’ products and is thus required to enter

into client-specific confidentiality and disclosure agreements with strict terms governing Singota’s storage, protection, and return of its clients’ confidential product information. [Id. at ¶¶ 23-24]. Ms. Attariwala was first employed as a Senior Business Development Manager for Singota in September 2015. [Id. ¶ 27]. In this role, she was responsible for promoting

Singota’s business and generating new client projects. As a Senior Business Development Manager, she maintained access to Singota’s confidential and proprietary information as well as Singota’s clients’ confidential and proprietary information. [Id. at ¶ 33]. As a condition of her employment with Singota, Ms. Attariwala executed an employment agreement in 2015 at the outset of her employment. [Id. at ¶ 27]. The employment agreement contained two restrictive covenants relevant to this litigation: a

covenant not to solicit certain Singota clients and prospective clients, and a covenant not to use, disclose, or misappropriate Singota’s confidential information. The non- disclosure provision specifically provides: Employee (i) shall use Confidential Information solely in connection with Employee’s employment with the Company; (ii) shall not directly or indirectly disclose, use or exploit any Confidential Information for Employee’s own benefit or the benefit of any other person or entity, other than the Company, both during and after Employee’s employment with the Company or as required by law; and (iii) shall hold Confidential Information in trust and confidence, and use all reasonable means to assure that it is not directly or indirectly disclosed to or copied by unauthorized persons or used in an unauthorized manner, both during and after Employee’s employment with the Company.

[Am. Compl., Exh. A]. The agreement defines confidential information as: [A]ny proprietary, confidential, or company-sensitive information and materials which are the property of or relate to the Company or business of the Company. Confidential Information shall include without limitation all information and materials created by, provided to, or otherwise disclosed to Employee in connection with Employee’s employment with the Company (excepting only information and materials already known by the general public), including without limitation (i) trade secrets, (ii) the names and addresses of the Company’s past, present or prospective contributors, beneficiaries or business contacts, and all information relating to such contributors, beneficiaries, or business contacts, regardless of whether such information was supplied or produced by the Company or such contributors, beneficiaries, or business contacts; and (iii) information concerning the Company’s affiliates, financing sources, profits, revenues, financial condition, fund raising activity, and investment activity, business strategies, and software used by the Company and associated layouts, templates, processes, documentation, databases, designs and techniques.

[Id.] The non-solicitation provision states:

During Employee’s employment with the Company and for a period of twelve (12) months (which shall be extended by the length of any period during which Employee is in violation of this section) immediately following the termination of Employee’s employment for any reason, Employee (on Employee’s own behalf or that of any other person or entity) shall not directly or indirectly sell or otherwise provide or solicit the sale or provision of any product or service that competes directly or indirectly with any business of the Company to any customer or prospective customer or prospective customer as to which, during the 12 months immediately preceding the date of termination, Employee (i) engaged in any solicitation, sales activity, or other direct contact (in person, in writing, by telephone or electronically) on behalf of the Company; (ii) performed any duties or services on behalf of the Company; and/or (iii) received any Confidential Information.

[Id.].

II. Ms. Attariwala’s Departure from Singota and Commencement of Employment with Emergent

In October 2018, Ms. Attariwala undertook negotiations with Emergent, a direct competitor of Singota, regarding her potential employment with that company. [Dkt. 85, Exh. A.] She ultimately accepted an offer from Emergent as a Senior Manager on December 11, 2018 and submitted her resignation to Singota on December 19, 2018. [Dkt. 85, at 7, 8]. She officially departed Singota later that month1 and commenced her employment with Emergent on February 11, 2019. [Id. at 9, 13].

1 It is unclear what precise date Ms. Attariwala left her employment with Singota. Following Ms. Attariwala’s departure, Singota began to suspect that Ms. Attariwala had breached the restrictive covenants of her employment agreement. [Id. at

10]. In late-December 2018, a review of Ms. Attariwala’s email revealed that she been in contact with Singota’s current and prospective clients to inform them of her transition to Emergent. She further notified these clients that she would be in contact with them in January once she settled into her new position. [Id.]. She also shared information about Emergent’s aseptic filling capabilities with at least one of these clients. [Id.] Upon discovering these communications, Singota issued a cease and desist letter

to Ms. Attariwala demanding that she comply with the terms of her employment agreement and that she immediately disclose to them any confidential or proprietary information that she had accessed following her departure. [Id. at 10-11, Exh. A]. Singota requested that Ms.

Free access — add to your briefcase to read the full text and ask questions with AI

BIOCONVERGENCE LLC v. ATTARIWALA, (S.D. Ind. 2019).

BIOCONVERGENCE LLC v. ATTARIWALA (BIOCONVERGENCE LLC v. ATTARIWALA) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Arbaugh v. Y & H Corp.
546 U.S. 500 (Supreme Court, 2006)
Scott Buethe v. Britt Airlines, Inc.
749 F.2d 1235 (Seventh Circuit, 1984)
Abbott Laboratories v. Mead Johnson & Company
971 F.2d 6 (Seventh Circuit, 1992)
Ty, Inc. v. The Jones Group, Inc.
237 F.3d 891 (Seventh Circuit, 2001)
GE Betz, Incorporated v. Zee Company, Incorporated
718 F.3d 615 (Seventh Circuit, 2013)
In Re RBGSC Investment Corp.
253 B.R. 369 (E.D. Pennsylvania, 2000)
Ackerman v. Kimball International, Inc.
652 N.E.2d 507 (Indiana Supreme Court, 1995)
Hydraulic Exchange & Repair, Inc. v. KM Specialty Pumps, Inc.
690 N.E.2d 782 (Indiana Court of Appeals, 1998)
Steve Silveus Insurance, Inc. v. Goshert
873 N.E.2d 165 (Indiana Court of Appeals, 2007)
U.S. Land Services, Inc. v. U.S. Surveyor, Inc.
826 N.E.2d 49 (Indiana Court of Appeals, 2005)
James Turnell v. Centimark Corporation
796 F.3d 656 (Seventh Circuit, 2015)
Craig Vickery v. Ardagh Glass, Inc.
85 N.E.3d 852 (Indiana Court of Appeals, 2017)
Star Scientific, Inc. v. Carter
204 F.R.D. 410 (S.D. Indiana, 2001)